Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119060059B details a novel three-step synthesis for Ritlecitinib Tosylate offering enhanced purity and scalable manufacturing efficiency for global pharmaceutical supply chains.
Novel N,N-coordinated rhodium complex enables high-yield reductive amination. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Novel cobalt method replaces rhodium and palladium for carbazole synthesis, offering significant cost reduction and high yields for pharmaceutical intermediates.
Patent CN102690239B reveals gold-catalyzed alkyne amination for 1,5-benzodiazepines. Achieves 100% atom economy, reducing waste and enhancing supply chain reliability for pharmaceutical intermediates.
Discover the novel preparation method for terbutaline sulfate via CN110950765A. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN121426782A details a novel Pd-catalyzed route for 2-aminoindole derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN117865874A details Pd-catalyzed olefin C-H amination for tetrahydroindole derivatives, offering high purity and scalable synthesis for pharmaceutical intermediates.
Patent CN107266414A reveals copper-catalyzed C-H amination for aminomethyl thiophenes. This method offers significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Patent CN107011218A details copper catalyzed asymmetric amination enabling efficient synthesis of chiral amines with improved supply chain reliability and cost effectiveness for global buyers
Novel anti-Markovnikov hydroamination method using rare earth catalysts offers high purity pharmaceutical intermediates with reduced environmental impact and simplified supply chains.
This patent details a novel method for producing high-purity 2-aminoindole derivatives using palladium catalysis, enabling cost-effective and scalable manufacturing with enhanced supply chain reliability for pharmaceutical intermediates.
Patented palladium-catalyzed C-H amination enables efficient production of high-purity tetrahydroindole derivatives with exceptional substrate versatility while reducing manufacturing complexity for pharmaceutical supply chains.
Breakthrough chiral biaryl pyridoxamine catalyst enables high-yield asymmetric transamination with mild conditions, offering reliable supply chain for pharmaceutical intermediates.
Patent CN112521289B enables copper-catalyzed synthesis with mild conditions and high atom economy for reliable pharmaceutical intermediate supply chains.
Solve fluorination challenges in drug development with this cost-effective, high-yield method. Ensure supply chain stability for active screening.
Solve PF-07321332 synthesis challenges: 76%+ yield, 98% purity, mild conditions. Eliminate -78°C steps & column chromatography. Scale to 100MT/yr.
Overcome low conversion rates in 7-azaindole synthesis with iridium-catalyzed C-H amination. Achieve 80-92% yields, reduced energy barriers, and scalable production for pharmaceutical intermediates.
Solve C-H amination challenges in 7-azaindole synthesis with iridium-catalyzed method. Achieve 80-92% yields, 12-36h reaction time, and superior selectivity for drug development. Reduce supply chain risks with scalable production.
Solve supply chain risks with 90%+ yield 3-chloro-4-amino maleimide synthesis. Copper-catalyzed, oxygen-tolerant process eliminates expensive anhydrous equipment. Contact for custom manufacturing.
Solve silodosin production challenges with 55.6% yield and 99.1% ee. Avoid difficult byproduct separation and reduce costs. CDMO expertise for scalable API manufacturing.